OtherNeuropharmacology
Pharmacologic activity of substituted tryptamines at 5-HT2AR, 5-HT2CR, 5-HT1AR, and SERT
Laura B Kozell, Amy J. Eshleman, Tracy L Swanson, Shelley H Bloom, Katherine M Wolfrum, Jennifer L Schmachtenberg, Randall J Olson, Aaron J. Janowsky and Atheir I Abbas
Journal of Pharmacology and Experimental Therapeutics January 20, 2023, JPET-AR-2022-001454; DOI: https://doi.org/10.1124/jpet.122.001454
Laura B Kozell
1Psychiatry, Oregon Health & Sciences University, United States
Amy J. Eshleman
2Research Service (R & D 22), VA Medical Center, United States
Tracy L Swanson
3OHSU, United States
Shelley H Bloom
4VAPORHCS, United States
Katherine M Wolfrum
5VAMC, United States
Jennifer L Schmachtenberg
4VAPORHCS, United States
Randall J Olson
6Oregon Health & Science University, United States
Aaron J. Janowsky
7Department of Psychiatry, Oregon Health & Science University, United States
Atheir I Abbas
8Veterans Affairs Portland Health Care System, United States

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherNeuropharmacology
Substituted tryptamine activity at 5-HT receptors & SERT
Laura B Kozell, Amy J. Eshleman, Tracy L Swanson, Shelley H Bloom, Katherine M Wolfrum, Jennifer L Schmachtenberg, Randall J Olson, Aaron J. Janowsky and Atheir I Abbas
Journal of Pharmacology and Experimental Therapeutics January 20, 2023, JPET-AR-2022-001454; DOI: https://doi.org/10.1124/jpet.122.001454
OtherNeuropharmacology
Substituted tryptamine activity at 5-HT receptors & SERT
Laura B Kozell, Amy J. Eshleman, Tracy L Swanson, Shelley H Bloom, Katherine M Wolfrum, Jennifer L Schmachtenberg, Randall J Olson, Aaron J. Janowsky and Atheir I Abbas
Journal of Pharmacology and Experimental Therapeutics January 20, 2023, JPET-AR-2022-001454; DOI: https://doi.org/10.1124/jpet.122.001454
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement